Article Versions Notes

Neary M, Sharp J, Gallardo-Toledo E, Herriott J, Kijak E, Bramwell C, Cox H, Tatham L, Box H, Curley P, et al. Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters. Viruses. 2023; 15(8):1744. https://doi.org/10.3390/v15081744

Neary, Megan, Joanne Sharp, Eduardo Gallardo-Toledo, Joanne Herriott, Edyta Kijak, Chloe Bramwell, Helen Cox, Lee Tatham, Helen Box, Paul Curley, and et al. 2023. "Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters" Viruses 15, no. 8: 1744. https://doi.org/10.3390/v15081744

Neary, M., Sharp, J., Gallardo-Toledo, E., Herriott, J., Kijak, E., Bramwell, C., Cox, H., Tatham, L., Box, H., Curley, P., Arshad, U., Rajoli, R. K. R., Pertinez, H., Valentijn, A., Dhaliwal, K., Mc Caughan, F., Hobson, J., Rannard, S., Kipar, A., ... Owen, A. (2023). Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters. Viruses, 15(8), 1744. https://doi.org/10.3390/v15081744